Noninvasive approach to mend the broken heart: Is “remote conditioning” a promising strategy for application in humans?
- 1 October 2017
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 95 (10) , 1204-1212
Abstract
Currently, there are no satisfactory interventions to protect the heart against the detrimental effects of ischemia–reperfusion injury. Although ischemic preconditioning (PC) is the most powerful form of intrinsic cardioprotection, its application in humans is limited to planned interventions, due to its short duration and technical requirements. However, many organs/tissues are capable of producing “remote” PC (RPC) when subjected to brief bouts of ischemia–reperfusion. RPC was first described in the heart where brief ischemia in one territory led to protection in other area. Later on, RPC started to be used in patients with acute myocardial infarction, albeit with ambiguous results. It is hypothesized that the connection between the signal triggered in remote organ and protection induced in the heart can be mediated by humoral and neural pathways, as well as via systemic response to short sublethal ischemia. However, although RPC has a potentially important clinical role, our understanding of the mechanistic pathways linking the local stimulus to the remote organ remains incomplete. Nevertheless, RPC appears as a cost-effective and easily performed intervention. Elucidation of protective mechanisms activated in the remote organ may have therapeutic and diagnostic implications in the management of myocardial ischemia and lead to development of pharmacological RPC mimetics.Keywords
This publication has 92 references indexed in Scilit:
- Cardioprotection by Remote Ischemic Preconditioning is Blocked in the Aged Rat Heart in VivoJournal of Cardiothoracic and Vascular Anesthesia, 2017
- Remote ischemic preconditioning triggers changes in autonomic nervous system activity: implications for cardioprotectionPhysiological Reports, 2017
- Effect of hypercholesterolaemia on myocardial function, ischaemia–reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioningBritish Journal of Pharmacology, 2017
- Review of remote ischemic preconditioning: from laboratory studies to clinical trialsScandinavian Cardiovascular Journal, 2016
- Role of Pleiotropic Properties of Peroxisome Proliferator‐Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac ProtectionCardiovascular Therapeutics, 2016
- Delayed cardioprotective effects of WY-14643 are associated with inhibition of MMP-2 and modulation of Bcl-2 family proteins through PPAR-α activation in rat hearts subjected to global ischaemia–reperfusionCanadian Journal of Physiology and Pharmacology, 2013
- Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary interventionCatheterization and Cardiovascular Interventions, 2013
- Mechanisms and Prospects of Ischemic Tolerance Induced by Cerebral PreconditioningInternational Neurourology Journal, 2010
- The impairment of preconditioning-mediated cardioprotection in pathological conditionsPharmacological Research, 2009
- Angina-Induced Protection Against Myocardial Infarction in Adult and Elderly Patients: A Loss of Preconditioning Mechanism in the Aging Heart?JACC, 1997